David Mannino, MD
Internal Medicine · Lexington, KYNPI 1982628889
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $104,133 of the $168,281 with a category attached, or 61.9%. 18 manufacturers reported payments, led by AstraZeneca at 28.8% of the total. 2025 is the largest year on record at $55,874, more than ten times the $4,560 reported in 2019. Among internal medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $1294.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$48K
- GSK$37K
- F. Hoffmann-la Roche AG$20K
- Astrazeneca UK Limited$20K
- Regeneron Healthcare Solutions, Inc.$15K
- Genentech USA, Inc.$8K
- plus $20K from 12 others
Across 2 payments — averaging $375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$750
What the payments were for
- Consulting fees$104,13362%
- Speaking & faculty fees$28,15817%
- Travel & lodging$32,32319%
- Food & beverage$3,6552%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 43 | $48,424 |
| GSK | 17 | $36,593 |
| F. Hoffmann-la Roche AG | 8 | $20,417 |
| Astrazeneca UK Limited | 12 | $19,812 |
| Regeneron Healthcare Solutions, Inc. | 13 | $14,995 |
| Genentech USA, Inc. | 4 | $8,450 |
| Genentech, Inc. | 5 | $7,139 |
| Midmark Corporation | 4 | $4,276 |
| Amgen | 1 | $3,942 |
| Chiesi USA, Inc. | 1 | $3,000 |
| Mylan Specialty L.p. | 6 | $403 |
| Viatris Specialty LLC | 7 | $340 |
| Monaghan Medical Corporation | 1 | $150 |
| Boehringer Ingelheim | 2 | $123 |
| Verona Pharma, Inc. | 2 | $106 |
| Covis Pharma GmbH | 2 | $78 |
| Sanofi | 1 | $19 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$168,281 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $14,338 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $697 |
| Azithromycin | 31 | $192 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $36,593 | $14,33818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Lexington
- Fadi BachaLexington$31K
- Jad BalloutLexington$30K
- Thomas von UnrugLexington$22K
- Danilo CoralesLexington$17K
- Mohamed TashaniLexington$17K
- Kelli TrentLexington$16K
- Richard BeltLexington$14K
- Coutney SchniedersLexington$12K
- Fares KhaterWhitesburg$412K
- Bernard BuchananOwensboro$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.